Back to today’s briefing

Story perspectives

Trump's Drug Pricing Plan Sparks Innovation Concerns

5/7/2025

38 5

Summary

Story summary

President Trump is pushing for a "most favored nation" pricing model for Medicaid, which would tie U.S. drug prices to the lowest rates from other countries. While supporters see potential savings, critics warn it could stifle innovation, create drug shortages, and ultimately raise costs for patients, despite existing Medicaid rebates already slashing prices significantly.

1 of 1

Story summary

President Trump is pushing for a "most favored nation" pricing model for Medicaid, which would tie U.S. drug prices to the lowest rates from other countries. While supporters see potential savings, critics warn it could stifle innovation, create drug shortages, and ultimately raise costs for patients, despite existing Medicaid rebates already slashing prices significantly.